Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
ICU-acquired pneumonia and PaO2/FIO2 value accuracy: A new paradigm? Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015
Three years analysis of pulmary infections of mechanically ventilated patiens in adult intensive care unit Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015
As a risk factor of mortality in patients with sepsis in the intensive care unit and long term follow-up: Trombocytopenia Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
ICU and twelve-month mortality of patients with acute respiratory failure admitted to the ICU: What is the role of comorbidities? Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Impact of candida spp. colonization of respiratory tract in patients with intensive care unit-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Reasons of intensive care unit admission in COPD patients Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
Pneumonia in neutropenic patients with haematologic malignancies and disorders: Frequency and predictors of ICU admission at a tertiary care hospital in Karachi, Pakistan Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia Source: Annual Congress 2013 –COPD and infections Year: 2013
The treatment costs of ventilator associated pneuomonia in intensive care unit Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Predictors of length of stay in hospitalized patients with community acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Effect of giving antibiotics within 4 hours to patients with community-acquired pneumonia on mortality, length of stay and critical care admission Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
LATE-BREAKING ABSTRACT: How patients changed over 15 years: Outcomes and criticality of an Italian respiratory intensive care unit Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015
Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Patient outcomes following admission to UK tertiary referral cardio-thoracic intensive care unit: 1 year observational data Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014